Use of the Cobra catheter for targeted temperature management during cardiopulmonary bypass in swine  by Slater, Jared M. et al.
Use of the Cobra catheter for targeted temperature
management during cardiopulmonary bypass in swine
Jared M. Slater, BAa
Thomas A. Orszulak, MDb
Kenton J. Zehr, MDb
David J. Cook, MDa
Background: The purpose of this investigation was to determine whether tempera-
tures of the aortic arch and descending aortic circulations could be controlled
independently during cardiopulmonary bypass with a cannula possessing an en-
doaortic baffle (Cobra; Cardeon, Cupertino, Calif).
Methods: After Institutional Animal Care and Use Committee approval, 12 pigs
weighing 60 kg were started on bypass through a sternotomy. A dual-lumen
endoaortic cannula with a deployable baffle was used for arterial cannulation.
Bypass was initiated at 37°C, and control measurements were obtained. The baffle
was then inflated with saline solution, segmenting blood flow along the greater and
lesser curvatures of the aortic arch. Parallel heat exchangers were used to independ-
ently control temperature of the arch and descending aortic perfusates. Cerebral and
systemic temperatures were recorded continuously.
Results: During cardiopulmonary bypass, mean flow and arterial pressure were
maintained at 2.4 to 2.6 L  min1  m2 and 60 to 70 mm Hg, respectively. With
aortic flow distributed by the baffle, a 5°C temperature differential between brain
(30°C) and body (35°C) was established in a mean of 5  2 minutes. Mean brain
and corporeal temperatures of 27°C and 35°C were then maintained over 60
minutes. Relative to control, internal jugular and inferior vena cava oxygen satu-
rations increased during targeted temperature control with the device.
Conclusions: The Cobra cannula allows for independent control of brain and body
temperature while providing satisfactory hemodynamics. Application of this tem-
perature management strategy may offer cerebral protection and the advantages of
warm systemic bypass temperature.
Since the development of cardiopulmonary bypass (CPB), temperaturemanagement has been evolving.1 In the absence of heat exchangers,early bypass was conducted at relative normothermia. Thereafter,whole-body hypothermia became standard practice until the 1990s,when there was a shift to warmer bypass temperatures. Over the last5 years, systemic temperature for much of adult cardiac operations has
settled out near 33°C to 35°C. The reasons for these changes are complex. Warmer
bypass temperatures may be associated with hemodynamic benefits resulting from
the combination of better rhythm,1-6 higher cardiac output, and lower systemic
vascular resistance.3,6,7 Furthermore, because of the elimination of the need for
cooling and rewarming, the warm technique can be associated with shorter CPB
times.8-10 Additionally, although not all reports are in agreement, postoperative
bleeding may be less,11,12 and postoperative temperature afterdrop13,14 is probably
reduced. Finally, respiratory demands in the intensive care unit may be less, and this
has been shown by some authors to be associated with shorter times to extuba-
tion.7,15
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Although warm bypass temperatures have found accept-
ance,16-18 there are concerns over the neurologic effects of
this technique9,19 because hypothermia offers cerebral pro-
tection from ischemia.20 As such, the ability to selectively
control cerebral temperature independent of systemic tem-
perature may offer unique advantages, allowing for both the
potential cardiac, respiratory, and hematologic effects of
warm body temperature and the brain protection offered by
cerebral hypothermia.
A variety of techniques have been applied experimen-
tally and clinically to provide more selective hypothermic
cerebral protection. These have included topical cooling,
antegrade and retrograde cerebral perfusion, and isolation of
perfusion to the arch and descending aorta.21-23 The inno-
vation we examine here is segmentation of flow in the aortic
arch along the greater and lesser curvatures by means of a
deployable baffle and, through that, independent tempera-
ture control of the arch and descending aortic circulations.
Materials and Methods
After review and approval by the Institutional Animal Care and
Use Committee, fasting pigs (n  12) weighing 55 to 65 kg were
studied. Body surface area was determined by using a veterinary
table of values. Pigs were premedicated with tamsulosin (Telazol)
(4 mg/kg) and xylazine (2 mg/kg) intramuscularly. Anesthesia was
induced with 2% halothane in oxygen by mask, and the trachea
was intubated. Peripheral intravenous access was secured, and
muscle relaxation was obtained with pancuronium (0.2 mg/kg
intravenously). Ventilation was controlled to maintain PaCO2 at 35
to 40 mm Hg and a PaO2 at greater than 150 mm Hg. Anesthesia
was maintained with 0.5% to 1% halothane and a continuous
intravenous infusion of fentanyl (0.7 g  kg1  min1) and
ketamine (28 g  kg1  min1). Pancuronium (0.3 g  kg1 
min1) was administered to provide continuous muscle relaxation.
Four-inch 18-gauge catheters were surgically inserted into the
right femoral and left axillary arteries for blood sampling and
mean arterial blood pressure (MAP) monitoring of the corporeal
and arch circulations, respectively. Catheters were also placed into
the left internal jugular vein (threaded cephalad to the base of the
skull) and into the inferior vena cava (IVC) from the right femoral
vein.
A wire thermocouple was advanced 20 cm into the IVC
through the femoral vein catheter. Brain temperature was moni-
tored with a needle thermocouple placed 2 cm into the brain
through a parietal skull burr hole. The hole was then filled with
Surgicel, and the scalp was closed. Temperatures were recorded
each minute by using a multichannel recording system (TM-12;
Physitemp Instruments Inc, Clifton, NJ) and downloaded to a
laptop computer.
Blood gases and oxygen saturation (IL-BGE Analyzer and IL
482 Co-Oximeter; Instrumentation Laboratories, Inc, Boston,
Mass) from the femoral artery, IVC, and internal jugular vein were
obtained at each study period. Alpha-stat management was used at
all times when the perfusate was less than 37°C. Additionally,
blood gas data were continuously monitored during CPB by using
an in-line analyzer (CDI 400; Cardiovascular devices, Inc, Tustin,
Calif). A Delphin II (Sarns; 3M, Ann Arbor, Mich) ultrasonic flow
probe measured CPB flows in the arch and corporeal circulation.
Cannulation and CPB
The heart was approached through a sternotomy, and the pericar-
dium was reflected. A dual-lumen 24F cannula (Cobra; Cardeon
Inc, Cupertino, Calif), with an inflatable baffle capable of segment-
Figure 1. Photograph of the Cobra catheter. A, Endoaortic portion in profile demonstrating the descending aorta
perfusion port (1), the wing pillow (2) that minimizes distal flow around the baffle, and the sewing ring (3), which
prevents device migration. B, Endoaortic portion (top view) illustrating cannula baffle or wing (4) and arch
perfusion ports (5). C, Cobra cannula ex vivo demonstrating 2 proximal connection ports (6) and pilot balloon (7)
for baffle inflation.
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ing the greater and lesser curvatures of the aortic arch, was inserted
through a standard ascending aortotomy (Figure 1). The catheter
was inserted until the depth stop on the catheter was against the
adventitia of the ascending aorta (Figure 2). Venous drainage to
the extracorporeal circuit with a 2-stage 40F cannula was placed
through the atrial appendage.
The bypass circuit was primed with 1500 mL of crystalloid
solution. Blood from the venous cannula drained into a single
hard-shell cardiotomy reservoir and was pumped by means of a
centrifugal pump (Sarns, 3M) through a combined heat exchanger-
oxygenator (Bentley Univox, Irvine, Calif). Distal to the oxygen-
ator, a bifurcation in the tubing allowed warm oxygenated blood to
be delivered either to the cannula port supplying the distal (de-
scending aorta) lumen of the aortic cannula or to a second heat
exchanger (HE-30 GOLD; Bentley, Irvine, Calif) used to cool the
aortic arch perfusate. The hypothermic aortic arch perfusate was
subsequently delivered to the proximal ports of the aortic cannula.
Bypass was divided into 3 phases. The first period was control.
During this time, blood gases, total CPB flow (2.4-2.6 L  min1
 m2), MAP (60-70 mm Hg), and temperature (36°C-38°C) were
stabilized for at least 15 minutes. The second bypass period was
targeted temperature management (TTM). During TTM, the baffle
was inflated with saline solution until adequate filling was indi-
cated by a pilot balloon. The secondary heat exchanger was then
activated, and cooling continued until brain temperature was re-
duced by 8°C to 10°C, while at the same time maintaining a
corporeal temperature of 34°C or greater. This condition was
maintained for 60 minutes, after which the baffle was deflated,
cooling of the arch heat exchanger was stopped, and arch circula-
tion was allowed to warm (post-TTM period).
Figure 2. Schematic of the Cobra cannula in situ. Perfusion ports for the arch vessels are cephalad to the inflatable
baffle, and the port supplying the descending aorta is distal to the baffle.
TABLE 1. Physiologic data
Arch flow
(L  min1  m2)
Distal aortic flow
(L  min1  m2)
MAPax
(mm Hg)
MAPfem
(mm Hg)
Hemoglobin
(g/dL)
PaCO2
(mm Hg)
Before CPB 76 14 76 14 11.1 1.1 35 4
CPB
Control 1.1 0.3 1.6 0.3* 68 11 65 8 9.3 0.8† 37 3
TTM 0.8 0.2† 1.5 0.3* 67 8 59 9* 9.1 1.0† 37 3
After TTM 1.0 0.3 1.5 0.3* 65 8 65 8 9.0 1.2† 38 2
Ao, Aorta; MAPax, axillary artery MAP; MAPfem, femoral artery MAP.
* P  .05 between arch and distal aorta by means of paired t test after 2-way repeated-measures analysis of variance.
† P  .05 within groups by means of paired t test after 2-way repeated-measures analysis of variance.
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We determined the time required to reduce cerebral tempera-
ture 5°C or greater relative to IVC temperature and the duration of
time that the temperature differential was maintained. Duration of
time after TTM that cerebral temperature remained less than 35°C
was also determined.
Data Analysis
Changes in physiologic variables during the 3 study periods were
assessed by using 2-way repeated-measures analysis of variance.
When this test identified significance, a paired t test was used to
determine significance at each study period. Temperatures during
stable TTM are expressed as a time-weighted average. Data are
expressed as means  SD.
Results
The mean animal weight and body surface area were 60.5
3.1 kg and 1.5  0.1 m2, respectively.
Physiologic data at each study period are provided in
Table 1. Total CPB flow during the control bypass period
was 2.6 0.5 L  min1  m2, and MAP in the axillary and
femoral arteries was 68  11 and 65  8 mm Hg, respec-
tively (Table 1). During this time, the internal jugular
(SjvO2) and IVC venous oxygen saturations (SvO2) differed
(71%  11% and 55%  8%, respectively; P  .001;
Figure 3). During bypass, the hemoglobin concentration
was reduced relative to the prebypass period (Table 1).
When the cannula baffle was inflated, the mean flow
through the arch port of the aortic cannula was 0.8  0.2 L
 min1  m2, and flow through the descending aortic port
was 1.5  0.3 L  min1  m2 (Table 1). The mean total
flow during TTM was 2.4  0.4 L  min1  m2. During
TTM, the blood pressure in the arch circulation was greater
than that in the corporeal circulation (67 vs 59 mm Hg,
respectively; P  .037; Table 1).
Changes in brain and IVC temperatures during CPB are
illustrated in Figure 4. At the time TTM was initiated, the
mean brain and IVC (corporeal) temperatures were
36.6°C  1.0°C and 36.5°C  1.2°C, respectively. The
mean time to reach a 5°C differential between the 2 circu-
lations was 5  2 minutes. During TTM, the brain under-
went a mean 9°C temperature decrease, whereas the IVC
(corporeal) temperature decreased 2°C. The time-weighted
temperature averages for brain and corporeal circulations
during TTM were 26.8°C  2.9°C and 35.0°C  1.5°C,
respectively. Independent temperature control was main-
tained for 60  11 minutes.
During TTM, there was a significant increase in the
SjvO2 compared with that in the control period (90% 12%
vs 71%  11%, P  .004). Furthermore, the mean SjvO2
during TTM was significantly greater than the SvO2 meas-
ured in the IVC (P  .0001, Figure 3).
After 60 minutes, the baffle was deflated, and cooling of
the arch perfusate was stopped. The brain rewarmed to a
mean temperature of 35.4°C 2.0°C over 27.2°C 13.6°C
minutes. Cerebral hyperthermia was not observed in any
animal. Brain temperature remained below 35°C for 62%
15% of this period, whereas the SjvO2 remained elevated
relative to the control period (P  .003, Figures 3 and 4).
During all periods, the SjvO2 was greater than the SvO2
(Figure 2). Systemic venous oxygen saturation was also
higher after TTM (61%  5%) than in the control period
(55%  8%, P  .05).
Discussion
In this report we demonstrate that selective cerebral hypo-
thermia (27°C) and simultaneous warm body temperature
(35°C) can be readily achieved with the Cobra aortic can-
nula.
The device tested here evolved from an earlier one de-
signed to independently control arch and descending aortic
temperatures.23 The earlier design achieved isolation of the
arch and descending aorta by means of a balloon inflated in
the proximal descending aorta. In contrast, even partial
aortic occlusion is not necessary with the Cobra device.
Segmentation of aortic flow and temperature control is
achieved with a baffle that inflates orthogonal to the axis of
the transverse arch (Figure 5). This minimizes contact with
the aortic wall and effectively isolates flow along the lesser
and greater curvatures of the arch. Perfusion ports cephalad
to the baffle perfuse the arch vessels, and a distal and caudad
port supplies the descending aorta.
The CPB circuit requires little modification to achieve
TTM. A single pump head is used, and a second heat
exchanger is introduced to control arch temperature. Aortic
inflow is provided by 1⁄4-inch and 3⁄8-inch lines connected,
Figure 3. SjvO2 and IVC oxygen saturation (SvO2) during each CPB
study period (control, before TTM). Values are means  SD
(n  12). *P < .05 and P < .05 between study periods by means
of paired t test after 2-way repeated-measures analysis of vari-
ance. §P < .001 between SjvO2 and SjvO2 by means of paired t test
after 2-way repeated-measures analysis of variance when indi-
cated.
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respectively, to the arch and descending aortic ports of the
device (Figure 1).
Probably the most important practical question raised by
this modification of CPB practice is how much flow should
be directed to the arch and descending aortic circulations
when using this device. In this experiment (and in initial
clinical trials) a single pump head was used, and therefore
flow to the arch and descending aortic circulations is deter-
mined by the relative resistance of the circuit limbs and the
vascular resistance in those organ beds. This allows auto-
regulatory mechanisms to determine perfusion of the arch
and descending aortic circulations. Furthermore, the intrin-
sic resistance of the system was designed to achieve a high
arch flow relative to the body surface area perfused. This
accounts for the slightly higher MAP in the arch circulation
during TTM. A second critical design feature is that the
baffle is not occlusive proximally. As such, the relatively
high perfusion directed to the arch vessels overflows around
the baffle in the proximal aorta. This overflow has important
effects. The mixing of cold and warm blood in the proximal
aorta slightly cools the blood delivered down the descend-
ing aorta. This accounts for the 2°C to 3°C of cooling
demonstrated in the IVC temperature. Hemodynamically,
the nonocclusive design of the device also eliminates the
question as to how much flow should be directed to the arch
vasculature because arch perfusion is high and because the
arch cannot be overperfused as a result of the proximal
overflow that occurs. The adequacy of this design was
indicated in this experiment by means of the very rapid
reduction in brain temperature seen with initiation of TTM
and the large increases in cerebral venous oxygenation
saturations demonstrated.
A second primary consideration with any endoaortic
device, whether it is an intra-aortic balloon pump, emboli
trap, or Port-Access (Heartport Inc, Redwood City, Calif)
cannula, is the potential risk of embolization with device
placement. Very recently, this device has been used clini-
cally. In that investigation device application was contin-
gent on the assessment of aortic atherosclerosis with trans-
esophageal echocardiography, with grade IV disease as an
exclusion criteria. Although severe atheromatous disease
may be a relative contraindication to the use of any aortic
device, severe disease is only seen in 2% to 17% of patients
(depending on technique and grading scale).24-26 As such,
this type of device could have application in the majority of
adults undergoing cardiac surgery.
In addition to being able to independently control brain
and body temperature during bypass, this device has a
second very unique design effect. The continuous overflow
from the greater curvature of the arch to the lesser curvature
around the proximal aorta continuously washes emboli gen-
erated in the proximal aorta along the lesser curvature and
down the descending aorta. This protects the brain from
embolization. In an experimental swine model with 100-m
microspheres injected into the aortic root, embolization to
the brain was reduced approximately 90% with the Cobra
device, even in the absence of cerebral cooling.27 A greater
Figure 4. Brain (filled squares) and IVC (filled diamonds) temperature over the 3 phases of CPB. At time 0, targeted
TTM was initiated. *P < .05, brain versus IVC temperature by means of paired t test after 2-way repeated-measures
analysis of variance. Time-weighted mean  SD is given at 10-minute intervals (n  12).
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reduction in brain embolization would be predicted if cere-
bral cooling was combined with the effect of the baffle.
The use of this device late in bypass also deserves
comment. During standard bypass with induced hypother-
mia, cerebral hyperthermia is relatively common during
rewarming.28 This occurs because the warmest blood
enters the aorta just proximal to the carotid origins and
because cerebral blood flow is high. This can result in
cerebral oxygenation stress,29,30 and it is clear that small
degrees of hyperthermia can greatly aggravate neurologic
injury when ischemia occurs.20 In this study mild cerebral
hypothermia and favorable cerebral oxygen balance per-
sisted after deflation of the baffle, even when cooling of the
arch limb of the circuit was stopped. However, greater
cerebral benefit might result from continued perfusion of the
arch with a mildly hypothermic perfusate until closer to the
end of CPB.
A device of this design can extend the range of possi-
bilities for temperature management during CPB. The com-
bination of cerebral hypothermia with a body temperature of
about 34°C to 35°C may offer the best possible circum-
stances for optimizing neurologic and cardiovascular out-
comes. This device is unique in that regard. A large ran-
domized clinical trial determining the effect of this device
on neurologic, neurocognitive, and cardiopulmonary out-
comes has been initiated.
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